MedTrace Logo

Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

NCT01549340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8790

Last updated 2017-03-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the proportion of participants that initiate allergen immunotherapy (AIT) upon the recommendation of their physician and the proportion of participants that persist with their AIT throughout the recommended course.

Conditions

  • Perennial Allergic Rhinitis
  • Seasonal Allergic Rhinitis

Sponsors & Collaborators

  • ALK-Abelló A/S

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01549340 on ClinicalTrials.gov